24 Jul 2017

REUTERS: Mitsubishi Tanabe Pharma to buy Israel’s Neuroderm for $1.1 billion in U.S. push

Mitsubishi Tanabe Pharma to buy Israel’s Neuroderm for $1.1 billion in U.S. push

TOKYO (Reuters) – Japan’s Mitsubishi Tanabe Pharma Corp is acquiring Israeli drug maker Neuroderm for $1.1 billion in cash as part of a strategy to grow its business in the United States.

Read more here: http://www.reuters.com/article/us-neuroderm-m-a-mitsub-tanabe-idUSKBN1A90IA